Boai NKY Pharmaceuticals Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.038x

Boai NKY Pharmaceuticals Ltd cash flow conversion efficiency. Based on the latest financial reports, Boai NKY Pharmaceuticals Ltd (300109) has a cash flow conversion efficiency ratio of 0.038x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥139.46 Million ≈ $20.41 Million USD) by net assets (CN¥3.69 Billion ≈ $540.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Boai NKY Pharmaceuticals Ltd (2007–2025)

Cash flow conversion efficiency of Boai NKY Pharmaceuticals Ltd from 2007 to 2025. This chart illustrates how Boai NKY Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Boai NKY Pharmaceuticals Ltd stock price for real-time trading data and today's change.

Boai NKY Pharmaceuticals Ltd Cash Flow Conversion Ratio Explained

Boai NKY Pharmaceuticals Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Boai NKY Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Boai NKY Pharmaceuticals Ltd ranked by their cash flow conversion efficiency. Also see 300109 market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Dynamatic Technologies Limited NSE:DYNAMATECH	0.068x
Olectra Greentech Limited NSE:OLECTRA	-0.025x
Domino's Pizza Enterprises Limited F:HQX	0.082x
FAWER Automotive Parts Ltd Co SHE:000030	0.028x
GrocerIQ, Inc NYSE:WPFHD	N/A
TOA Paint (Thailand) Public Company Limited BK:TOA	0.054x
Cullinan Oncology LLC NASDAQ:CGEM	-0.126x
Major Drilling Group International TO:MDI	0.020x

Annual Cash Flow Conversion Efficiency for Boai NKY Pharmaceuticals Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of Boai NKY Pharmaceuticals Ltd from 2007 to 2025. Review free cash flow generation of Boai NKY Pharmaceuticals Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.66 Billion ≈ $534.86 Million	CN¥338.11 Million ≈ $49.48 Million	0.093x	+30.34%
2024-12-31	CN¥3.61 Billion ≈ $527.92 Million	CN¥256.03 Million ≈ $37.47 Million	0.071x	-48.84%
2023-12-31	CN¥3.52 Billion ≈ $515.09 Million	CN¥488.25 Million ≈ $71.45 Million	0.139x	+71.74%
2022-12-31	CN¥3.12 Billion ≈ $456.15 Million	CN¥251.77 Million ≈ $36.84 Million	0.081x	+532.17%
2021-12-31	CN¥3.40 Billion ≈ $497.55 Million	CN¥43.44 Million ≈ $6.36 Million	0.013x	-85.27%
2020-12-31	CN¥3.08 Billion ≈ $450.15 Million	CN¥266.87 Million ≈ $39.05 Million	0.087x	+232.53%
2019-12-31	CN¥3.05 Billion ≈ $446.69 Million	CN¥79.64 Million ≈ $11.65 Million	0.026x	-31.79%
2018-12-31	CN¥1.28 Billion ≈ $186.75 Million	CN¥48.81 Million ≈ $7.14 Million	0.038x	+5.36%
2017-12-31	CN¥1.30 Billion ≈ $190.58 Million	CN¥47.28 Million ≈ $6.92 Million	0.036x	-60.99%
2016-12-31	CN¥1.23 Billion ≈ $179.49 Million	CN¥114.14 Million ≈ $16.70 Million	0.093x	+68.78%
2015-12-31	CN¥1.16 Billion ≈ $170.16 Million	CN¥64.12 Million ≈ $9.38 Million	0.055x	-52.64%
2014-12-31	CN¥400.25 Million ≈ $58.57 Million	CN¥46.60 Million ≈ $6.82 Million	0.116x	+89.44%
2013-12-31	CN¥377.06 Million ≈ $55.18 Million	CN¥23.17 Million ≈ $3.39 Million	0.061x	+8.28%
2012-12-31	CN¥363.81 Million ≈ $53.24 Million	CN¥20.65 Million ≈ $3.02 Million	0.057x	+405.33%
2011-12-31	CN¥350.93 Million ≈ $51.35 Million	CN¥3.94 Million ≈ $576.77K	0.011x	-62.77%
2010-12-31	CN¥333.21 Million ≈ $48.76 Million	CN¥10.05 Million ≈ $1.47 Million	0.030x	-93.44%
2009-12-31	CN¥62.14 Million ≈ $9.09 Million	CN¥28.57 Million ≈ $4.18 Million	0.460x	+593.63%
2008-12-31	CN¥43.93 Million ≈ $6.43 Million	CN¥-4.09 Million ≈ $-598.80K	-0.093x	-117.36%
2007-12-31	CN¥17.82 Million ≈ $2.61 Million	CN¥9.56 Million ≈ $1.40 Million	0.536x	--

About Boai NKY Pharmaceuticals Ltd

SHE:300109 China Specialty Chemicals

Market Cap

$894.77 Million

CN¥6.11 Billion CNY

Market Cap Rank

#9020 Global

#2132 in China

Share Price

CN¥10.60

Change (1 day)

-1.03%

52-Week Range

CN¥10.60 - CN¥20.47

All Time High

CN¥149.39